Bookmark and Share
LYPLA1 (geneid:10434) - Gene BioActivity Data
Also known as: APT-1, APT1, LPL-I, LPL1, hAPT1.
BioActivity Outcomes:
Probe(2)
 
 
Active(863)
 
 
Inactive(314873)
 
 
Unspecified(4)
 
 
BioAssay Types:
Screening(315579)
 
 
 
Literature(8)
 
 
 
Confirmatory(5)
 
 
 
 
Summary(2)
 
 
BioActivity Types:
IC50(3)
 
 
 
Substance Types:
Chemical(315735)
 
 
 
 
 
RNAi(7)
 
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 19    Data Row: 315742   Total Pages: 6315   Display: Page     
Sort: [Click the result table header to sort]
#StructureSubstanceCompoundActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID99445332]
[CID71304779]
Summary of probe development efforts to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2202, Type: summary] [gi:5453722]
View
2
[SID99445338]
[CID56593118]
Summary of probe development efforts to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2202, Type: summary] [gi:5453722]
View
3
[SID160654487]
[CID3238952]
0.21Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical dose-response gel-based ABPP [AID651990_1, Type: confirmatory] [gi:5453722]
View
4
[SID160654486]
[CID3238952]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1: LCMS-based cell-based Activity-Based Protein Profiling (ABPP) SILAC selectivity analysis in situ [AID651979_1, Type: other] [gi:5453722]
View
5
[SID160654486]
[CID3238952]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition and selectivity [AID651988_1, Type: other] [gi:5453722]
View
6
[SID160654487]
[CID3238952]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical gel-based ABPP evaluation of activity in situ [AID651986_1, Type: other] [gi:5453722]
View
7
[SID160654487]
[CID3238952]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical gel-based ABPP gel filtration assay to assess binding mode [AID651987_1, Type: other] [gi:5453722]
View
8
[SID49665687]
[CID3099740]
Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] [gi:5453722]
View
9
[SID85148654]
[CID22586]
Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] [gi:5453722]
View
10
[SID160654493]
[CID1081005]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition and selectivity [AID651988_1, Type: other] [gi:5453722]
View
11
[SID160709328]
[CID70697696]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1: LCMS-based Activity-Based Protein Profiling (ABPP) SILAC selectivity analysis in vitro, Set 2 [AID652018_1, Type: other] [gi:5453722]
View
12
[SID160709325]
[CID70697710]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1: LCMS-based Activity-Based Protein Profiling (ABPP) SILAC selectivity analysis in vitro, Set 2 [AID652018_1, Type: other] [gi:5453722]
View
13
[SID160709332]
[CID70697687]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1: LCMS-based Activity-Based Protein Profiling (ABPP) SILAC selectivity analysis in vitro, Set 2 [AID652018_1, Type: other] [gi:5453722]
View
14
[SID160709335]
[CID70697702]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1: LCMS-based Activity-Based Protein Profiling (ABPP) SILAC selectivity analysis in vitro, Set 2 [AID652018_1, Type: other] [gi:5453722]
View
15
[SID160709341]
[CID70697705]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1: LCMS-based Activity-Based Protein Profiling (ABPP) SILAC selectivity analysis in vitro, Set 2 [AID652018_1, Type: other] [gi:5453722]
View
16
[SID160709342]
[CID70697695]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1: LCMS-based Activity-Based Protein Profiling (ABPP) SILAC selectivity analysis in vitro, Set 2 [AID652018_1, Type: other] [gi:5453722]
View
17
[SID160709349]
[CID70697691]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1: LCMS-based Activity-Based Protein Profiling (ABPP) SILAC selectivity analysis in vitro, Set 2 [AID652018_1, Type: other] [gi:5453722]
View
18
[SID85148735]
[CID8428]
Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] [gi:5453722]
View
19
[SID85148735]
[CID8428]
Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of lysophospholipase 1 (LYPLA1). [AID2233, Type: screening] [gi:5453722]
View
20
[SID85148896]
[CID44144090]
Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] [gi:5453722]
View
21
[SID85148896]
[CID44144090]
Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of lysophospholipase 1 (LYPLA1). [AID2233, Type: screening] [gi:5453722]
View
22
[SID49666794]
[CID2885134]
Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] [gi:5453722]
View
23
[SID49665326]
[CID3109741]
Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] [gi:5453722]
View
24
[SID49665326]
[CID3109741]
Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of lysophospholipase 1 (LYPLA1). [AID2233, Type: screening] [gi:5453722]
View
25
[SID49665497]
[CID1565495]
Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] [gi:5453722]
View
26
[SID49665497]
[CID1565495]
Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of lysophospholipase 1 (LYPLA1). [AID2233, Type: screening] [gi:5453722]
View
27
[SID49666747]
[CID1483729]
Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] [gi:5453722]
View
28
[SID49818888]
[CID24817717]
Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] [gi:5453722]
View
29
[SID49818888]
[CID24817717]
Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of lysophospholipase 1 (LYPLA1). [AID2233, Type: screening] [gi:5453722]
View
30
[SID49821996]
[CID979180]
Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] [gi:5453722]
View
31
[SID49821996]
[CID979180]
Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of lysophospholipase 1 (LYPLA1). [AID2233, Type: screening] [gi:5453722]
View
32
[SID81066646]
[CID42628412]
Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] [gi:5453722]
View
33
[SID81066646]
[CID42628412]
Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of lysophospholipase 1 (LYPLA1). [AID2233, Type: screening] [gi:5453722]
View
34
[SID49665986]
[CID2766260]
Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] [gi:5453722]
View
35
[SID49666417]
[CID3498566]
Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] [gi:5453722]
View
36
[SID49666417]
[CID3498566]
Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of lysophospholipase 1 (LYPLA1). [AID2233, Type: screening] [gi:5453722]
View
37
[SID49667427]
[CID940770]
Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] [gi:5453722]
View
38
[SID49667427]
[CID940770]
Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of lysophospholipase 1 (LYPLA1). [AID2233, Type: screening] [gi:5453722]
View
39
[SID49819869]
[CID9639903]
Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] [gi:5453722]
View
40
[SID49818988]
[CID24817742]
Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] [gi:5453722]
View
41
[SID49818988]
[CID24817742]
Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of lysophospholipase 1 (LYPLA1). [AID2233, Type: screening] [gi:5453722]
View
42
[SID49822084]
[CID979181]
Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] [gi:5453722]
View
43
[SID49822084]
[CID979181]
Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of lysophospholipase 1 (LYPLA1). [AID2233, Type: screening] [gi:5453722]
View
44
[SID49823068]
[CID8036957]
Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] [gi:5453722]
View
45
[SID49823068]
[CID8036957]
Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of lysophospholipase 1 (LYPLA1). [AID2233, Type: screening] [gi:5453722]
View
46
[SID24780863]
[CID5752755]
Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] [gi:5453722]
View
47
[SID17402168]
[CID3513626]
Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] [gi:5453722]
View
48
[SID17402168]
[CID3513626]
Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of lysophospholipase 1 (LYPLA1). [AID2233, Type: screening] [gi:5453722]
View
49
[SID24781867]
[CID16187670]
Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] [gi:5453722]
View
50
[SID24781867]
[CID16187670]
Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of lysophospholipase 1 (LYPLA1). [AID2233, Type: screening] [gi:5453722]
View